Idiopathic pulmonary fibrosis (IPF), also known as cryptogenic fibrosing alveolitis, is a
distinct form of interstitial lung disease of unknown etiology that is limited to the lung; it is …

The long-standing need to determine an effective medical treatment regimen with clinically
significant and relevant end-points to improve outcome for patients with idiopathic …

INTRODUCTION—Idiopathic pulmonary fibrosis (IPF; also called cryptogenic fibrosing
alveolitis) is specific form of chronic, progressive, fibrosing interstitial pneumonia of unknown …

The clinical course of idiopathic pulmonary fibrosis (IPF) is variable; however, the long-term
survival in IPF is poor. Prednisone has been the mainstay of therapy since its release for …

Idiopathic pulmonary fibrosis (IPF) is a devastating illness for which current therapy is
minimally effective. If medical therapy for IPF is going to improve over the next decade …

Idiopathic pulmonary fibrosis (IPF), or crypto-genic fibrosing alveolitis, is a disorder
characterized by intense alveolar inflammation, disruption of the pulmonary vascular bed …

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive fibrosing interstitial pneumonia
of unknown cause that is limited to the lungs [1]. The disease is inevitably fatal, with an …

Idiopathic pulmonary fibrosis (IPF), also termed cryptogenic fibrosing alveolitis, is a
clinicopathological syndrome characterised by cough, exertional dyspneoa, basilar crackles …

Idiopathic pulmonary fibrosis (IPF) is a relentlessly progressive lung disease in most cases,
and effective treatment is still lacking. This review examines the current status of treatment …

Idiopathic pulmonary fibrosis (IPF) is the most prevalent of the idiopathic interstitial
pneumonias and its incidence seems to be increasing [1–4]. IPF is generally considered to …